Search
for
Sort by
Research 541–570 of 1000+
- Understanding and managing common baldness.
- Role of systemic minoxidil in the treatment of alopecia areata: A scoping review to direct future research
- Are bald men more virile than their well thatched contemporaries?
- Skin manifestations of polycystic ovary syndrome
- Summation and recommendations for the safe and effective use of topical and oral minoxidil
- Health‐related quality of life of adult and adolescent patients living with alopecia areata in Australia
- Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double‐blind, placebo‐controlled, phase 1B clinical trial
- Female pattern hair loss in men: A distinct clinical variant of androgenetic alopecia
- Epidermal Cells Expressing Putative Cell Markers in Nonglabrous Skin Existing in Direct Proximity with the Distal End of the Arrector Pili Muscle
- α<sub>1</sub>-AR agonist induced piloerection protects against the development of traction alopecia
- Regrowth of black hair in two red‐haired alopecia areata patients
- Fetal growth following temporary exposure of day 3 ovine embryos to an advanced uterine environment
- Alopecia areata
- Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
- Integrated Safety Analysis of Ritlecitinib for the Treatment of Alopecia Areata (AA) From the Phase 2 and Phase 3 ALLEGRO Clinical Trial Program
- Does topical minoxidil at concentrations higher than 5% provide additional clinical benefit?
- Bicalutamide improves minoxidil-induced hypertrichosis in female pattern hair loss: A retrospective review of 35 patients
- Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil treatment in Brazilian female pattern hair loss patients
- Common causes of paediatric alopecia
- Androgenetic alopecia. Modelling progression and regrowth
- Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment
- Scalp hair parameter changes in transgender individuals commencing gender-affirming hormone therapy: A 24-week prospective observational study
- 67 Patterns of clinical response in patients with alopecia areata (AA) treated with ritlecitinib in the ALLEGRO phase 2b/3 and ongoing, phase 3, ALLEGRO-LT studies
- Alopecias in humans: biology, pathomechanisms and emerging therapies
- Novel topical booster enhances follicular sulfotransferase activity in patients with androgenetic alopecia: a new strategy to improve minoxidil response
- Treatment of chronic alopecia areata with tildrakizumab: an open‐label pilot study
- Novel shampoo reduces hair shedding by contracting the arrector pili muscle via the trace amine‐associated receptor
- Hair transplantation in mice: Challenges and solutions
- The effect of ovine secreted soluble factors on human dermal papilla cell aggregation
- Iododerma in pregnancy secondary to iodinated multivitamins